Virtual Reality Cognitive Therapy for Alzheimer's Disease

Completed · Phase 1

Conditions studied: Alzheimer Disease

In brief

To evaluate the usability, feasibility, and acceptability of VRCT iteratively on 36 AD/ADRD individuals with mild to moderate CI.

Key facts

Study ID

NCT05788848

Run by

Claritytek, Inc.

People needed

36

Starts

2023-03-31

Expected to finish

2024-08-31

Last updated by the study team

2024-12-30

Who can join

Age: 30 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of mild cognitive impairment (MCI), probable Alzheimer's disease (AD) or Alzheimer's disease Related Dementias (ADRD)
• Montreal Cognitive Assessment (MoCA) score of 11-25
• Age 30-89

You may not qualify if…

• Non-English speaking
• History of seizure disorder, vertigo disorder, or severe motion sickness that would impact their ability to participate in the intervention
• History of any other serious condition that may limit their ability to participate in the intervention, as determined by the investigators.
• Inability to use the VR device (e.g., severe visual/hearing impairment, aphasia, facial injuries)

Where it is running

• HealthPartners — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.